VKVera V. Knyshova

Vera V. Knyshova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vera V. Knyshova has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Tatyana P. Novgorodtseva

    Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment

    9 shared publications
  • Marina V. Antonyuk

    Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment

    7 shared publications
  • Yuliya K. Denisenko

    Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment

    6 shared publications
  • Tatyana A. Gvozdenko

    Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment

    5 shared publications
  • Tatyana Isaakovna Vitkina

    Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Institute of Medical Climatology and Rehabilitative Treatment

    4 shared publications
  • Oksana Yu. Kytikova

    Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment

    3 shared publications

Latest Publications

  • Open Access

    Neurotrophins as a Link Between Cells Involved in the Pathogenesis of Asthma

    by O. Yu. Kytikova, M. V. Antonyuk, V. V. Knyshova, T. P. Novgorodtseva, T. A. Gvozdenko, О. Ю. Кытикова, М. В. Антонюк, В. В. Кнышова, Т. П. Новгородцева, Т. А. Гвозденко

    Currently, research into the pathogenesis of bronchial asthma focuses primarily on immune inflammation and airway remodeling. Both the immune and nervous systems are involved in the development of airway inflammation. Neurotrophic factors, particularly neurotrophins, are expressed by both neuronal and non-neuronal cells. In the lungs, neuro trophins are expressed by epithelial cells, alveolar and interstitial macrophages, eosinophils, and lymphocytes. Disruption of the relationship between nerve, epithelial, and immune cells in the lungs may play a significant role in the pathophysiological changes associated with bronchi al asthma. Aim . The aim of this study is to systematize current knowledge about the neuroimmune mechanisms of bronchial asthma and the role of neurotrophins in mediating the interactions between immune, epithelial cells, and neurons involved in the development of bronchi al hyperreactivity, eosinophilic inflammation, and airway remodeling. Materials and Methods . A narrative literature review was per formed, encompassing 97 publications from 2016 to 2025, to examine the interactions between neurotrophins, immune cells, epithelial cells, and neurons in asthma. Results . Both allergic and non-allergic asthma share an identical inflammatory response mechanism, which is driven by the production of leukocyte-derived, epithelial-derived, and neuro genic mediators and ultimately leads to airway remodelling. The paper discusses the interplay between airway immune inflammation and nervous system activity in a feedback-loop manner. On the one hand, parasympathetic, sympathetic, and sensory neurons act via ILC2-expressed receptors to induce contraction or relaxation of bronchial smooth muscle cells and to trigger or suppress Th2-type inflammation. On the oth er hand, mediators secreted by immune cells stimulate neurons to produce neurotrophins and neuropeptides. Cell survival capacity depends on the number and profile of receptors for neurotrophic factors. The article outlines the currently known pathways of neurotrophin interactions with the nervous and immune systems. Conclusion . The need for further research to elucidate the possibility of regulating neuroimmune disorders is substantiated.

  • Open Access

    The association of metabolic dysregulation with neuroimmune airway inflammation in asthma

    by O. Yu. Kytikova, T. P. Novgorodtseva, M. V. Antonyuk, V. V. Knyshova, T. A. Gvozdenko, О. Ю. Кытикова, Т. П. Новгородцева, М. В. Антонюк, В. В. Кнышова, Т. А. Гвозденко

    Neuroimmune mechanisms and their role in the pathogenesis of asthma have been actively discussed in the scientific literature in recent years. There is emerging evidence of a relationship between neurotrophic factors and lipid metabolism in asthma. Despite the significance of existing research, the literature is insufficient to support a neuro-immune-lipid model of asthma that defines the pathogenetic relationship between these three systems. Brain-derived neurotrophic factor (BDNF) is implicated in the pathogenesis of bronchial hyperreactivity and remodeling, integrating the neuroimmune mechanisms of asthma pathogenesis. Lipid metabolism disturbances in asthma, including an imbalance of proinflammatory and anti-inflammatory lipid mediators, as well as changes in sphingolipid and cholesterol levels in cell membranes, can influence the expression of BDNF and its receptor, which form the BDNF/TrkB signaling pathway. This allows us to consider the relationship between lipids and neurotrophins as a mechanism linking metabolic dysregulation with neuroimmune inflammation and airway remodeling in asthma. In this mechanism, lipids are considered to act as mediators modulating BDNF activity by activating signaling pathways that regulate BDNF gene transcription. Further research will help substantiate a unified neuro-immune-lipid model of asthma pathogenesis.

  • Сomplex rehabilitation treatment of patients with stage III discirculatory encephalopathy

    by Elena V. Moroz, Marina V. Antonyuk, Vera V. Knyshova, Vladimir N. Potapov

    BACKGROUND: The main task in the treatment of stage III dyscirculatory encephalopathy is to prevent the rapid progression of cognitive impairment and improve the quality of life of patients. It is assumed that the integrated use of non-drug and drug treatment methods makes it possible to correct impaired neuropsychological functions in this category of patients. OBJECTIVE: To evaluate the integrated use of cognitive training and low-frequency pulsed magnetic therapy to optimize the rehabilitation treatment of patients with stageIII dyscirculatory encephalopathy. MATERIAL AND METHODS: An open prospective comparative study was conducted in which 185patients aged 60–85years with a diagnosis of stageIII discirculatory encephalopathy took part. Group1 (n=60) included patients who received drug therapy and cognitive training, group2 (n=64)— drug therapy, cognitive training and low-frequency pulsed magnetic therapy; group3 (n=61)— only medications. The course of treatment was 3months. The effectiveness of rehabilitation treatment was assessed by changes in neurological status, short-term and long-term memory tests (10-word test), attention (correction test), functional independence in everyday life, and rehabilitation potential. Long-term results were assessed 3 months after completion of the course of treatment. RESULTS: After the course of treatment, patients in group1 demonstrated an increase in short-term and long-term memory by 83% (p0.05) and 65.8% (p0.05), a decrease in the number of errors in the proofreading test by 11% (p0.05), neurological disorders by 13% (p0.05), and an increase in RP to a high level in 35% of patients. The effects were leveled out three months after the course of treatment. In group2, short-term and long-term memory increased by 82% (p0.05) and 66% (p0.05), attention by 36% (p0.05), neurological disorders decreased by 19% (p0.05), functional independence of patients according to the IADL scale increased by 27% (p0.05) and RP to a high level in 70.3% of patients. The therapeutic effects persisted for three months after the course of treatment. The most effective was the complex with cognitive training and low-frequency pulsed magnetic therapy (2nd group).

  • Associations Of Fatty Acid Composition In Leukocyte Membranes With Systemic Inflammation In Chronic Obstructive Pulmonary Disease Progression

    by Yulia K. Denisenko, Tatyana P. Novgorodtseva, Tatyana I. Vitkina, Vera V. Knyshova, Marina V. Antonyuk, Nataliya V. Bocharova, Oxana Yu. Kytikova

    Background — The development of systemic inflammation is a key pathogenetic mechanism in progression of chronic obstructive pulmonary disease (COPD). Fatty acids (FAs) and their oxidized derivatives serve as essential regulators of inflammation. The relationship between systemic inflammation and FA metabolism in COPD is poorly understood. In our research, we focused on examining the FA composition of the leukocyte membrane in COPD and the FA metabolism in association with systemic inflammation. Objective — We examined 137 patients with mild, moderate, or severe COPD. The control group comprised 32 healthy non-smokers. Methods — Blood cytokines and immune cell subpopulations were evaluated by flow cytometry. The FA composition of the leukocyte membranes was analyzed by gas chromatography. The concentrations of eicosanoids (thromboxane B2 (TXB2), leukotriene B4 (LTB4)) in plasma were measured by ELISA. Results — Our results implied systemic inflammation in all patients with COPD. The analysis of the FA composition of leukocyte membrane demonstrated increased level of saturated FAs and n-6 polyunsaturated fatty acids (PUFAs), along with reduced levels of monounsaturated FAs and n-3 PUFAs, in patients with COPD. The TXB2 and LTB4 content was increasing in COPD patients. We established a significant correlation with n-6 PUFAs, immune cells, and cytokines, which was indicative of an important role of FAs in the progress of systemic inflammation in COPD. Conclusion — Thus, FA modification of immune cells in patients with chronic pathologies of the bronchopulmonary system leads not only to disruption of the cell membrane structure, but also to the pathology of immune response regulation, and contributes to the development of the inflammatory process. The latter is a decisive factor in the pathogenesis of COPD.


  • Open Access

    Features of immune response in different phenotypes of chronic obstructive pulmonary disease

    by M. V. Antonyuk, E. E. Mineeva, V. V. Knyshova, A. V. Urenko, T. I. Vitkina, T. P. Novgorodtseva, T. A. Gvozdenko

    Chronic obstructive pulmonary disease (COPD) is considered a heterogeneous disorder exhibiting different phenotypes. Chronic systemic inflammation is an important link in the COPD pathogenesis. The studies of immune response in the context of clinical and functional phenotypes seems relevant. Objective of our work was to study the features of immune response in clinical and functional phenotypes of COPD.Eighty-three COPD patients of different severity grade and 22 apparently healthy volunteers were examined. After determining the COPD phenotype by clinical and functional signs, the patients were divided in two groups, i.e., 38 subjects with bronchitis, and 45 patients with emphysematous phenotype. Clinical, functional and laboratory research was carried out in standard mode. Static lung volumes and respiratory capacities were investigated, i.e., functional residual capacity, residual lung volume, total lung capacity, bronchial resistance on inspiration and expiration to assess phenotype of the disease. Subpopulations of Th1 and Th17 lymphocytes were determined by the level of blood serum cytokines, tumor necrosis factor (TNFá), interleukins (IL) IL-4, IL-10, IL-17A, IFNã).Different features of immune response were revealed in bronchitic and emphysematous phenotypes of the COPD patients. Activation of inflammatory process with differentiation of naive T lymphocytes along the Th1-dependent pathway was found in 68% of cases with bronchitis and 16% of patients with emphysematous phenotypes. As compared with control group, the patients showed a statistically significant increase in the level of TNFá, IFNã, along with decrease in IL-4. Development of immune response by the Th17 type was found in 32% of cases with bronchitis, and 84% of cases with emphysematous phenotypes. Its emergence was associated with increased IL-17A and IL-10 levels, and a decrease in IFNã/IL-17A compared to the control. Differentiation of T helper cells towards Th1 pathway of immune response has been shown to predominate in bronchitic phenotype and at early stages of the disease. The Th17 type of immune response prevailed with increasing severity of the disorder. In emphysematous phenotype of COPD, the Th17-pathway of immune response develops at early stages of the disease. Some relationships are revealed between the systemic inflammation indexes and functional parameters of external respiration. An inverse relationship between TNFá and the OOL/OEL ratio in Th1 type of immune response has been shown. A direct correlation was found between the level of IL-17A and the parameters of external respiration function (FEV1, FEV1/FVC), as well as between IFNã/IL-17A and functional residual capacity in Th17 type of immune response.The type of immune response is associated with severity of the disease, as well with clinical and functional phenotype of COPD. Progression of the disease, broncho-obstructive disorders and hyperinflation are associated with increased levels of cytokines that provide cell polarization along the Th17 pathway. Determination of COPD phenotype and the type of immune response already at an early stage of the disease will enable prediction of its course and justify the choice of phenotype-oriented therapy.


  • Open Access

    Regulatory signal mechanisms of systemic inflammation in respiratory pathology

    by Tatyana P. Novgorodtseva, Tatyana A. Gvozdenko, Tatyana I. Vitkina, Yuliya K. Denisenko, Marina V. Antonyuk, Vera V. Knyshova

    At present time, the pathogenesis of various diseases is considered in terms of typical pathological processes. One of the main typical pathological processes is inflammation, a universal complex of genetically programmed reactions to any phologogenic agents. Pathophysiological changes in chronic respiratory diseases are caused by local inflammation in the airways that results in bronchial obstruction, destructive processes in the lung parenchyma, remodeling of the lung tissue and disruption of gas exchange [1-3].


  • Open Access

    FEATURES OF CYTOKINE PROFILE IN PATIENTS WITH BRONCHIAL ASTHMA COMBINED WITH OBESITY

    by M. V. Antonyuk, T. A. Gvozdenko, T. P. Novgorodtseva, T. I. Vitkina, B. I. Geltser, A. V. Yurenko, E. E. Mineeva, V. V. Knyshova

    Combination of bronchial asthma (BA) and obesity is a difficult-to-control phenotype. Studies of inflammatory process with respect to severity of the disease are important for understanding the potential influence of obesity on the BA clinical course. The objective of this study was to determine cytokine profile in patients with mild BA combined with obesity. The study involved fifty-three patients with partially controlled mild BA. The patients were recruited as volunteers and signed an informed consent. The first observation group consisted of 27 asthma patients with normal body weight, the second observation group consisted of 26 patients with BA combined with obesity. A control group included 25 healthy volunteers. All the patients underwent clinical and laboratory examination in accordance with clinical standards for BA and obesity. The levels of TNFα, IL-2, IL-4, IL-6, IL-10 were evaluated in blood serum by means of flow cytometry. The ratios of proand anti-inflammatory cytokines (TNFα/IL-4, TNFα/IL-10, IL-6/IL-4, IL-6/IL-10) were calculated. Asthma patients with obesity (the 2nd group) had elevated levels of IL-2 over control group and group 1, by 38% and 44% respectively(p < 0.05). The concentration of proinflammatory cytokines TNFα and IL-6 was significanty increased in the both patient groups. Mean TNFα level was increased 2.5 times (p < 0.05), and IL-6 levels were increased by 30% (p < 0.05) in the 1st group as compared to the controls. TNFα and IL-6 concentrations showed a 3-fold increase over control values (p < 0.05) in the 2nd group. The level of antiinflammatory cytokine IL-4 was increased in patients with BA, independently of body mass. It should be noted that the concentration of this cytokine in obese patients was higher by 29% than in patients with normal body weight. IL-10 levels in patients from the 2nd group were reduced more than 2 times than in the 1st group. The patients of the 1st group showed a decrease in the IL-6/IL-10 index, in comparison with control parameters, thus indicative of an imbalance due to the elevation of the anti-inflammatory IL-10 cytokine. Among BA patients with obesity (group 2) the TNFα/IL-10 and IL-6/IL-10 indexes were higher than those of the control group (2.3- and 5.5-fold, respectively) and the group 1 (2.6- and 2.5-fold, respectively). Dynamics of these indexes confirms the systemic nature of inflammation and a predominance of non-atopic inflammation in asthma patients with obesity. Thus, features of the cytokine profile in BA with obesity consist of a significant increase in pro-inflammatory IL-2, IL-6, TNFα cytokines, and a relative decrease in anti-inflammatory IL- 10 cytokine. The development of BA with obesity, even in mild-severity BA, is accompanied by development of a cytokine disbalance, which is typical for a mixed-type inflammation, with a prevalence of neutrophil inflammation.


  • Open Access

    CLINICAL AND IMMUNOLOGICAL COMPARISONS IN Th- DEPENDENT IMMUNE RESPONSE MECHANISMS AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    by E. P. Kalinina, T. I. Vitkina, V. V. Knyshova, E. A. Fedoseeva, T. P. Novgorodtseva, T. A. Gvozdenko

    Хроническая обструктивная болезнь легких (ХОБЛ) является глобальной проблемой здравоохранения. Актуальным является изучение иммунологических особенностей и их сопряженности с клиническим течением ХОБЛ. Цель исследования – установить клинико-иммунологические особенности ХОБЛ разной степени тяжести при Th1- и Тh17-зависимых типах иммунного ответа. Обследовано 132 пациента с ХОБЛ и 32 практически здоровых лица. По клинико-функциональным вариантам пациенты с ХОБЛ разделены по группам: 36 человек (28%) с легкой степенью тяжести, 62 человека (48%) со средней степенью тяжести и 30 человек (23%) с тяжелой степенью тяжести. Проводилось клинико-функциональное и лабораторное исследование. Субпопуляции Th1- и Th17- лимфоцитов оценивали по уровню цитокинов в сыворотке крови (туморнекротизирующий фактор (TNFα), интерлейкинов (IL) IL-4, IL-10, IL-17А, IL-21, IFNγ), трансформирующего фактора роста β1 (TGF-β1)), определяли экспрессию рецептора IL-6R (CD126+) на зрелых Т-лимфоцитах (CD3+) и Т-хелперах (CD4+) периферической крови. Результаты исследования показали, что у больных ХОБЛ легкой степени тяжести определялись три разных фенотипа с превалированием Th1-зависимого иммунного ответа. Уровень экспрессии IL-6R представлен в большей степени на CD3+CD126+ клетках при Th1/Th17-фенотипе и CD4+CD126+ клетках при Th17-зависимом типе иммунного ответа. У больных ХОБЛ средней степени тяжести соотношение между Th1-, Th17- и Th1/Th17-типами иммунного ответа определялось в равных долях. Уровень экспрессии IL-6R на зрелых Т-лимфоцитах и Т-хелперах возрастает в наибольшей степени при Th17-зависимом иммунном ответе. У больных ХОБЛ тяжелой степени преобладал иммунный ответ по Th17- и Th1/Th17-типам. Уровень экспрессии IL-6R увеличивается при Th17- и Th1/Th17- зависимых типах иммунного ответа, при этом наиболее значимое возрастание отмечается для CD4+ клеток при Th17-фенотипе. Установлено, что с фенотипами иммунного ответа у пациентов с ХОБЛ сопряжены особенности клинического течения заболевания. Полученные данные позволят определить фенотип воспаления, спрогнозировать течение хронического заболевания и подобрать адекватную терапию.


  • Open Access

    The Mechanisms of the Regulation of Immune Response in Patients with Comorbidity of Chronic Obstructive Pulmonary Disease and Asthma

    by Elena P. Kalinina, Yulia K. Denisenko, Tatyana I. Vitkina, Elena G. Lobanova, Tatyana P. Novgorodtseva, Marina V. Antonyuk, Tatyana A. Gvozdenko, Vera V. Knyshova, Anna V. Nazarenko

    Background. Comorbidity of chronic obstructive pulmonary disease (COPD) and asthma (asthma COPD overlap syndrome, ACOS) is a significant problem in pulmonary practice, whose pathogenetic issues are not clarified yet.Objective. To study the features of the regulation of immune response in patients with comorbid COPD and asthma.Methods. We assessed the levels of CD3+, CD4+, CD8+, CD4+/CD8+, CD19+, CD25+, HLA-DR, total IgE, TNF-α, IL-4, IFN-γ, TXB2, and LTB4in patients with comorbid COPD and asthma.Results. The study involved 44 people with COPD, 39 people with asthma, and 12 people with comorbid COPD and asthma. The specific features in comorbid COPD and asthma were lymphocytosis, increased absolute count of T-helper cells, increased cytotoxic T-lymphocytes in relative and absolute count, increased relative and absolute numbers of B-lymphocytes, and high levels of total IgE. The elevated levels of TNF-αand IL-4 and inhibition of IFN-γproduction were detected. The content of LTB4was maximal; TXB2levels were higher than in control group but lower than in COPD and asthma.Conclusion. In comorbid COPD and asthma inflammation increased even during stable period. High levels of eicosanoids, low production of Th1-type cytokines, and active synthesis of opposition IL-4, along with increased IgE, indicate the activation of Th2-type immune response.


  • The influence of sinusoidal modulated currents on the fatty acid composition of plasma and blood erythrocytes in the patients presenting with chronic cholecystitis

    by V. V. Knyshova, Yu. K. Denisenko, T. P. Novgorodtseva, A. V. Yurenko, T. A. Gvozdenko, N. V. Zhukova

    The results of this study give evidence that it is advisable to treat the patients presenting with chronic cholecystitis by sinusoidal modulated currents in the combination with the oral intake of exogenous polyunsaturated fatty acids.